Mechanism and clinical evaluation of abaloparatide, a new therapeutic agent for osteoporosis

doi:10.3969/j.issn.1672-3384.2018.07.008

PDF(3701 KB)

Clinical Medication Journal ›› 2018, Vol. 16 ›› Issue (7) : 37-40. DOI: 10.3969/j.issn.1672-3384.2018.07.008

Mechanism and clinical evaluation of abaloparatide, a new therapeutic agent for osteoporosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 16(7): 37-40 https://doi.org/10.3969/j.issn.1672-3384.2018.07.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(3701 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2018-05-26	2018-07-31
Issue Date
2018-07-31

Please choose a citation manager

Content to export